Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins

References

• ParsonsJKMougeyJLambertLLower urinary tract symptoms increase the risk of falls in older menBJU Int20091041 63 6819154508
   PubMed Web of Science ®Google Scholar
• StonerEThe clinical development of a 5-alpha-reductase inhibitor, finasterideJ Steroid Biochem Mol Biol199037 375 3781701660
   PubMed Web of Science ®Google Scholar
• SnyderPJAndrogensBrutonLLLazoJSParkerKLGoodman and Gilman’s the Pharmacological Basis of Therapeutics11th edNew York, NYMcGraw-Hill2006 1573 1585
   Google Scholar
• RathnayakeDSinclairRMale androgenetic alopeciaExpert Opin Pharmacother2010118 1295 130420426708
   PubMed Web of Science ®Google Scholar
• ParsonsJKSchenkJMArnoldKBFinasteride reduces the risk of incident clinical benign prostatic hyperplasiaEur Urol2012622 234 24122459892
   PubMed Web of Science ®Google Scholar
• The United States Pharmacopoeia/The National Formulary30th edRockvilleUS Pharmacopeial Convention2007 2133 2135
   Google Scholar
• European Pharmacopoeia4th edParisCouncil of Europe2002 1188 1189
   Google Scholar
• MaynardRLThe Index Merck (Monograph Number: 4113)13th edNew York, NYMerck2001 721 722
   Google Scholar
• LoftssonTDuchêneDCyclodextrins and their pharmaceutical applicationsInt J Pharm20073291–2 1 1117137734
   PubMed Web of Science ®Google Scholar
• MadyFMAbo-TalebAKhalidKAEvaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidineInt J Pharm20103971–2 1 820600734
   PubMed Web of Science ®Google Scholar
• JambhekarSSBreenPCyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiencyDrug Discov Today2016212 363 36826687191
   PubMed Web of Science ®Google Scholar
• ValleEMMDCyclodextrins and their uses: a reviewProcess Biochem200439 1033 1046
   Web of Science ®Google Scholar
• AsbahrACCFrancoLBarisonASilvaCWPFerrazHGRodriguesLNCBinary and ternary inclusion complexes of finasteride in HP-β-CD and polymers: preparation and characterizationBioorg Med Chem2009177 2718 272319282187
   PubMed Web of Science ®Google Scholar
• HiguchiTConnorsKAAdvances in Analytical Chemistry and InstrumentationIVNew York, NYWiley Interscience1965
   Google Scholar
• YokotaTTonozukaTShimuraYIchikawaKKamitoriSSakanoYStructures of Thermoactinomyces vulgaris R-47 alpha-amylase II complexed with substrate analoguesBiosci Biotechnol Biochem2001653 619 62611330677
   PubMed Web of Science ®Google Scholar
• ShityakovSSalmasREDurdagiSCharacterization, in vivo evaluation, and molecular modeling of different propofol–cyclodextrin complexes to assess their drug delivery potential at the blood–brain barrier levelJ Chem Inf Model20165610 1914 192227589557
   PubMed Web of Science ®Google Scholar
• CaseDACheathamTE3rdDarden TiSThe Amber biomolecular simulation programsJ Comput Chem20052616 1668 168816200636
   PubMed Web of Science ®Google Scholar
• RadwanMOSonodaSEjimaTZinc-mediated binding of a low-molecular-weight stabilizer of the host anti-viral factor apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3GBioorg Med Chem20162418 4398 440527475536
   PubMed Web of Science ®Google Scholar
• KaneRNKuchekarBSPreparation, physicochemical characterization, dissolution and formulation studies of telmisartan cyclodextrin inclusion complexesAsian J Pharm201041 52 59
   Google Scholar
• MousaviSHHKobarfardFHusainSWA rapid, simple, liquid chromatographic-electrospray ionization, ion trap mass spectrometry method for the determination of finasteride in human plasma and its application to pharmacokinetic studyIran J Pharm Res2012111 59 6725317185
   PubMed Web of Science ®Google Scholar
• BrewsterMELoftssonTCyclodextrins as pharmaceutical solubilizersAdv Drug Deliv Rev2007597 645 66617601630
   PubMed Web of Science ®Google Scholar
• CarrierRLMillerLAAhmedIThe utility of cyclodextrins for enhancing oral bioavailabilityJ Control Release20071232 78 9917888540
   PubMed Web of Science ®Google Scholar
• RamaACRVeigaFFigueiredoIVSousaACaramonaMAspectos biofarmacêuticos da formulação de medicamentos para neonatos. Fundamentos da complexação de indometacina com hidroxipropil-β-ciclodextrina para tratamento oral do fechamento do canal arterial [Biopharmaceutical aspects of formulation of medicines for neonates. Basics of Indomethacin complexation with hydroxypropyl-β-cyclodextrin for oral treatment of ductus arteriosus closure]Braz J Pharm Sci200541 281 Portuguese
   Google Scholar
• LoftssonTHreinsdóttirDMássonMEvaluation of cyclodextrin solubilization of drugsInt J Pharm20053021–2 18 2816099118
   PubMed Web of Science ®Google Scholar
• LiNLiuJZhaoXComplex formation of ionic liquid surfactant and β-cyclodextrinColloids Surf A2007292 196 201
   Web of Science ®Google Scholar
• LiWLuBShengAYangFWangZSpectroscopic and theoretical study on inclusion complexation of beta-cyclodextrin with permethrinJ Mol Struct2010981 194 203
   Web of Science ®Google Scholar
• RibeiroLLoftssonTFerreiraDVeigaFInvestigation and physicochemical characterization of vinpocetine-sulfobutyl ether beta-cyclodextrin binary and ternary complexesChem Pharm Bull2003518 91412913228
   PubMed Web of Science ®Google Scholar
• ZingoneGRubessaFPreformulation study of the inclusion complex warfarin-beta-cyclodextrinInt J Pharm20042911–2 315707726
   PubMed Web of Science ®Google Scholar
• AhmadiPGhasemiJB3D-QSAR and docking studies of the stability constants of different guest molecules with beta-cyclodextrinJ Incl Phenom Macrocycl Chem201379 401 413
   Web of Science ®Google Scholar
• AlyUFEnhancement of solubility and dissolution of atorvastatin calcium: in-vitro and in-vivo evaluationAlex J Pharm Sci2011252 83 90
   Google Scholar
• De-ChasteignSFessiHDavissaguetJPPuisieusxFComparative study of the association of Itraconazole with colloidal drug carrierDrug Dev Res1996382 125 133
   Web of Science ®Google Scholar
• AstrayGMejutoJCMoralesJRial-OteroRSimal-GándaraJFactors controlling flavors binding constants to cyclodextrins and their applications in foodsFood Res Int201043 1212 1218
   Web of Science ®Google Scholar
• KfouryMAuezovaLFourmentinSGreige-GergesHJInvestigation of monoterpenes complexation with hydroxypropyl-β-cyclodextrinJ Incl Phenom Macrocycl Chem201480 51 60
   Web of Science ®Google Scholar
• MathironDMarçonFDubaeleJMCailleuDPilardSDjedaïni-PilardFBenefits of methylated cyclodextrins in the development of midazolam pharmaceutical formulationsJ Pharm Sci20131027 2102 211123609010
   PubMed Web of Science ®Google Scholar
• CorriganOIStanleyCTMechanism of drug dissolution rate enhancement from beta-cyclodextrin-drug systemsJ Pharm Pharmacol19823410 621 6266128383
   PubMed Web of Science ®Google Scholar
• AhmedTAEl-SayKMMahmoudMFSamyAMBadawiAAMiconazole nitrate oral disintegrating tablets: in vivo performance and stability studyAAPS PharmSciTech2012133 760 77122585373
   PubMed Web of Science ®Google Scholar
• NairABAttimaradMAl-DhubiabBEWadhwaJHarshaSAhmedMEnhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrinDrug Deliv2014217 540 54724215288
   PubMed Web of Science ®Google Scholar
• BalakrishnanPSongCKChoH-JInclusion complex effect on the bioavailability of clotrimazole from poloxamer-based solid suppositoryArch Pharm Res2012357 1169 117522864739
   PubMed Web of Science ®Google Scholar